Fifth Third Bancorp
RXRX icon

Fifth Third Bancorp’s Recursion Pharmaceuticals RXRX Stock Holding History

Fifth Third Bancorp’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.97K Buy
+2,270
New +$8.77K ﹤0.01% 3779
2025
Q2 		– Sell
-146
Closed -$772 – 2632
2025
Q1 		$772 Buy
+146
New +$1.06K ﹤0.01% 2422

Other funds holding RXRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fifth Third Bancorp's RXRX Position: Q1 2026 in Review

Fifth Third Bancorp opened a new position in Recursion Pharmaceuticals (RXRX) in Q1 2026: 2,270 shares worth $6.97K. The stake represents ﹤0.01% of the portfolio and ranks #3779 among its holdings. This is a return to the name: Fifth Third Bancorp previously reported a position in RXRX as recently as Q1 2025.

Fifth Third Bancorp first reported a position in RXRX in Q1 2025 and has held it in 2 quarters since. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

  • Fifth Third Bancorp held 2,270 shares of Recursion Pharmaceuticals worth $6.97K as of Q1 2026.
  • Recursion Pharmaceuticals was a new Fifth Third Bancorp position in Q1 2026.
  • Recursion Pharmaceuticals made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #3779 holding.
  • Fifth Third Bancorp first reported a position in Recursion Pharmaceuticals in Q1 2025 and has held it in 2 quarters since.
  • 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.